DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 211 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,257,031 | +405.4% | 1,026,086 | +310.4% | 0.22% | +40.0% |
| Q3 2016 | $2,623,000 | -28.0% | 250,000 | 0.0% | 0.16% | -28.3% |
| Q2 2016 | $3,645,000 | -24.2% | 250,000 | 0.0% | 0.22% | -17.1% |
| Q1 2016 | $4,810,000 | -20.4% | 250,000 | 0.0% | 0.27% | -10.9% |
| Q4 2015 | $6,040,000 | -12.3% | 250,000 | -10.9% | 0.30% | -24.5% |
| Q3 2015 | $6,888,000 | +51.2% | 280,700 | +44.3% | 0.40% | +61.9% |
| Q2 2015 | $4,556,000 | +59.4% | 194,500 | +52.7% | 0.25% | +14.9% |
| Q1 2015 | $2,858,000 | – | 127,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 6,557,816 | $84,726,983 | 3.92% |
| Chicago Capital, LLC | 5,810,468 | $75,071,249 | 3.38% |
| Bain Capital Life Sciences Investors, LLC | 2,415,000 | $31,201,800 | 3.21% |
| PFM Health Sciences, LP | 2,704,917 | $34,947,528 | 1.36% |
| Rhenman & Partners Asset Management AB | 700,000 | $9,044,000 | 0.95% |
| AlphaCentric Advisors LLC | 110,000 | $1,421,200 | 0.79% |
| MIZUHO MARKETS AMERICAS LLC | 682,707 | $8,820,574 | 0.58% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,876,000 | 0.57% |
| Rock Springs Capital Management LP | 1,813,758 | $23,433,753 | 0.56% |
| Intrinsic Edge Capital Management LLC | 499,273 | $6,450,607 | 0.46% |